ORIC Pharmaceuticals, Inc. ( ORIC) - Key Metrics
ORIC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.38 | -$0.29 | -$0.30 |
| 2026Q1 | $0 | -$0.34 | -$0.31 | -$0.31 |
| 2025Q4 | $0 | -$0.35 | -$0.26 | -$0.26 |
| 2025Q3 | $0 | -$0.33 | -$0.25 | -$0.25 |
| 2025Q2 | $0 | -$0.47 | -$0.39 | -$0.40 |
ORIC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.13 |
| 2026Q1 | 0% | -9.32 |
| 2025Q4 | 0% | -6.82 |
| 2025Q3 | 0% | -9.09 |
| 2025Q2 | 0% | -5.40 |
ORIC
Price: $13.87
52 week price:
Earnings Per Share: -1.30 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 145300
Market Capitalization: 1.4 billion